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KARPAWICH, P.P., ET AL.: A new low threshold platinized epicardial pacing electrode: comparative
evaluation in immature canines. A prospective comparison of pacing and sensing capabilities between
the conventional Medtronic Model 49S1 platinum-iridium epicardial pacing electrode and a new modifted
"platinized" version of the' same electrode was performed in immature canines to determine if the new
electrode design improves pacing in the immature myocardium. The conventional electrode was modifted
by electroplating platinum black particles onto the surface to increase the effective or true microscopic
surface area, yet essentially maintain the same overall geometric electrode size. Both epicardial electrodes
were inserted into the right ventricular myocardium with the lead pad sutured to the epicardium, and
externalized to the scruff in jive puppies (age 3 months). An additional left ventricular lead was implanted
to permit chronic pacing following epicardially-induced atrioventricular block. Acute and chronic sensing
and pacing capabilities of each externalized electrode were performed at implant and weekly up to 4
months. Histologic examination of each electrode implant site was performed at the end of the study
period. At implant, both electrodes exhibited comparable values for sensed R waves, lead impedances, and
pacing thresholds. During the study, the platinized electrode exhibited lower pacing thresholds. Analysis of
all postimplant data demonstrated this threshold difference to be signiftcantly lower (P < .01) for the
platinized version. Lead impedance and sensing capabilities remained comparable between the two de-
signs. Histologic study demonstrated less fibrotic injiltration at the platinized electrode site. This prelimi-
nary evaluation indicates that for the duration of the postimplant study period, the platinized epicardial
electrode design was associated with signiftcantly lower thresholds and less ftbrosis as a function of time
compared to the conventional smooth electrode surface design. The new platinized electrode limits exit
block in the developing immature myocardium and permits safe pacing at lower pulse widths and voltages
to increase battery life. (PACE, Vol. 11, August 1988)
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Introduction
Electrode implant site fibrosis and exit block
have been limiting factors to chronic epicardial
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and epimyocardial pacing in the young. Although
recent application of the transvenous electrode
implant approach to the pediatric age group has
partially alleviated this problem.P the need for
efficient epicardial pacing persists. This need is
most expressed in the very young and in those
children with adverse cardiac or vascular anat-
omy which precludes the transvenous approach
to cardiac pacing. Recent epicardial electrode de-
signs which permit a limited depth of electrode
penetration combined with secondary fixation
characteristics are currently available and dem-
onstrate improved pacing capability over pre-
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vious designs which caused extensive myocardial
trauma.v" However, epicardial pacing continues
to exhibit less effective chronic thresholds than
the endocardial approach. The more recent intro-
duction of steroid-eluting'" and platinum-plated"
endocardial pacing electrodes have demonstrated
consistently better pacing and sensing thresholds
than otherwise standard endocardial electrodes.
Similar comparisons with epicardial electrodes
are lacking.
This study represents the initial comparison
of acute and chronic pacing and sensing capabili-
ties between the standard polished platinum-irid-
ium and new "platinized" versions of the Med-
tronic Model 4951 (Medtronic Inc., Minneapolis,
MN, USA) "fish hook" epicardial pacing electrode
in the immature, developing canine myocardium.
The study was undertaken to determine if the
new electrode surface design improves myocar-
dial tissue-electrode reactivity and permits im-
proved pacing capability in the young myocar-




Five immature beagle puppies (age 3 months)
were used in the study. All were instrumented
following anesthesia with intravenous sodium
pentobarbital and ventilated with room air fol-
lowing endotracheal intubation. Following a
midline thoracotomy, the pericardium was in-
cised to expose the right ventricle. In each animal,
both a standard and new platinized version of the
Medtronic Model 4951 epicardial pacing lead
were sutured to the right ventricle, 1 em apart.
Electrode implant sites were alternated between
animals to permit a nonbiased interpretation of
myocardial reactivity. An additional left ventric-
ular electrode, Medtronic Model 6917-35T, was
also attached to later permit chronic pacing.
Electrode Design
The Medtronic Model 4951 epicardial elec-
trode is a unipolar lead, insulated with polyure-
thane (Pellethane 2363-80A). A distal 0.41 in. (11
mm) X 0.75 in. (19 mm) epicardial polyurethane
pad provides stability for the electrode. A semi-
circular patch of Dacron fabric is attached to the
proximal epicardial side of the pad to provide
chronic fixation.
The electrode is formed from .020 diameter
platinum alloy wire. The sharpened tip and distal
barb provided a penetration and stabilizing con-
figuration. The electrode surface area is nomi-
nally 10 mm." With the addition of the platinized
finish, the true microscopic surface area is signifi-
cantly increased, even though the macroscopic
surface area remains at 10 mm."
Platinization of the formed electrode is a
three-step process. First, a two-stage acid boil and
rinse process prepares the electrode material for
electroplating. Then, platinum-black is deposited
by electrochemical means using a D.C. voltage
applied to the electrode while suspended in a
platinizing solution. Finally, the electrode is
rinsed in deionized water for several hours fol-
lowed by an oven bake to dry.
The particles and their agglomerates are of
such a small size that they absorb visible light
resulting in a black appearance. This results in an
extremely fine textured surface (Figures 1 and 2).
Implant Technique
Following fixation of both right ventricular
electrodes, acute pacing, and sensing measure-
ments were obtained using a Model 5311 pacing
system analyzer (Medtronics, Inc.). Implant mea-
surements for each electrode included voltage
threshold at 0.5 milliseconds (ms), pulse width
threshold at 2.5 and 5 volts (v), lead impedance,
and sensed myocardial R waves. A single left ven-
tricular electrode was also attached and con-
nected to an implanted pulse generator, Med-
tronic Model 8423 set in the VVI mode. After de-
termination of optimal electrode position, each
animal underwent transepicardial His bundle
mapping and formation of complete atrioventric-
ular block by direct epicardial formalin infiltra-
tion into the bundle of His." Chronic left ventricu-
lar pacing was then instituted.
The terminal ends of each right ventricular
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Figure 1. Electonmicroscopic appearance of conventional smooth plotinum-iridium electrode
surface. Calibration in lower right is 1 micron. Magnification is 4800X.
Figure 2. Comparative appearance of same platinum-iridium electrode after "platiniza tion"
illustrating fine microtextured surface on the order of 1 micronmeter or less. Magnification 4800X.
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lead were then externalized to the scruff to later
permit threshold and lead impedance testing. In
this manner, the additional variable of cathode
and anode electrodes was avoided in this small
population preliminary study. The thoracotomy
was closed in the usual fashion, and the animals
allowed to recover. Weekly pacing and sensing
characteristics of each externalized lead were de-
termined in each puppy in the awake, nonsedated
state using the pacing system analyzer. Measure-
ments included lead impedance, voltage thresh-
olds at 0.05, 0.1, 0.3, 0.5, 0.8, and 2 ms, as well as
pulse width thresholds at 2.5,5, and 10 v. Thresh-
old was determined at each output setting by de-
cremental programming the desired parameter
until capture was lost, then incremental program-
ming to capture. Threshold was defined as the
lowest value prior to loss of capture.
At the termination of the study, each animal
was sacrificed and the excised hearts fixed (10%
Table I.
Electrode Pacing and Sensing Comparison at lrnplant" Mean Values
Polished Platinum Platlnized pValue
Rwave 21 mV 20 mV NS
THR
(2.5 V) 0.2ms 0.1 ms NS
PWTHR
(0.5 ms) 0.4V 0.6 V NS
Impedance 449 n 404 n NS
at Explant** Mean Values
Polished Platinum Platinized p Value
Rwave 21+mV 21+mV NS
THR
(2.5 V) 0.3ms 0.3ms NS
PWTHR 2.1 V 0.9 V NS
(0.5 ms) 3.4 ma 1.4 ma
Impedance 562 n 549 n NS
Post Implant*** Mean Values
Measure Units Polished Platinum Platinlzed pValue
Rwave mV 20.8+(47) 19.6+(47) NS
THR
(2.5 V) ms .3 (43) .1 (43) P < .005
PWTHR V 1.8 (43) 1.1 (43) P < .01
(0.05 ms) ma 3.1 (43) 1.8 (43)
Impedance n 546 (47) 534 (47) NS
• N = 5 systems.
•• N = 3 systems. The two infected systems are excluded from in the data
••• Using three systems with repeated measurements over time. Two infected systems were excluded from the
data. The number of measurements given in parenthesis.
THR: Threshold. PW: pulse width.
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formalin) for gross and microscopic examination
of each electrode implant site using hematoxylin
and eosin and trichrome staining methods. Spe-
cific attention was given to fibrotic changes in the
myocardium.
Stastical Analysis
Implant data from each electrode version was
compared using the paired t-test, with signifi-
cance defined as a P value of 0.05. The small num-
ber of final electrodes tested precisely at explant,
however, precluded any effective determination
of significance using the paired t-test. Instead,
consideration was taken of the random variation
between the systems and within the systems for
the duration of the postimplant period. All the
postirnplant data was therefore analyzed together
using unbalanced random effects one-way analy-
sis of variance. In this manner, each electrode
Table II.
Threshold (V/mA at 0.5 rns) Versus Implant Time
Platlnlzed Platinum Polished Platinum
Canines 1 2 3 4 5 1 2 3 4 5
Weeks 1 1.2 1.3 .7 2.6 2.8 1.8 1.8 1.5 2.6 2.9
2.5 2.5 1.7 4.3 5.4 3.5 2.8 3.7 4.3 5.5
2 1.1 1.2 .7 2.1 1.8 1.4 1.7 1.5 2.3 2.3
2.0 2.2 1.7 3.1 2.6 2.7 2.9 3.4 3.7 3.9
3 .9 1.6 .7 1.8 1.8 1.3 1.5 1.6 2.1 2.2
1.7 3.0 1.7 2.7 2.9 2.5 2.7 3.8 3.1 3.5
4 .8 1.8 .6 1.8 1.4 1.6 2.2 2.2 2.0
1.5 3.3 1.4 2.7 2.6 2.8 4.9 3.0 3.5
5 .8 .5 1.9 1.5 1.8 2.1
1.5 1.2 2.8 2.7 4.4 3.0
6 .7 .6 1.7 1.5 1.7 1.9
1.3 1.5 2.6 2.4 4.3 2.9
7 .7 .6 1.5 1.3 1.7 1.7
1.3 1.4 2.1 2.3 4.3 2.4
8 .6 .8 1.5 1.5 2.2 1.7
1.0 1.3 2.1 2.6 3.5 2.4
9 .8 .8 1.4 1.4 2.7 1.8
1.4 1.4 2.2 2.5 4.1 2.6
10 .8 .9 1.4 1.4 3.2 1.9
1.4 1.5 2.3 2.4 5.1 2.9
11 .8 .7 1.5 1.5 3.2 1.9
1.4 1.3 2.4 2.6 3.8 2.9
12 .8 1.3 1.5 2.0
1.5 2.0 2.8 2.8
13 .9 1.3 1.4 1.9
1.8 2.0 2.6 2.9
14 .8 1.3 1.4 1.9
1.5 1.8 2.7 2.6
15 .9 1.2 1.4 2.0
1.6 1.5 2.4 2.9
16 .8 1.3 1.3 1.8
1.6 1.5 2.3 2.1
"Infected
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version underwent up to 47 measurements to
permit a more accurate determination of signifi-
cance.
Results
Acute electrical implant and chronic explant
data are listed in Table I. During the study, two
systems became infected and are excluded from
the explant data. At implant, there was no signifi-
cant difference in any measured value between
the two electrode versions. Table II lists voltage
and milliampere (rna) thresholds obtained in each
puppy at 0.5 ms pulse width, correlated over time.
Mean values (± standard error of the mean) for
threshold are illustrated in Figure 3. The new
platinized version exhibited consistently lower
threshold values for the duration of the study.
2.5
Ventricular threshold strength-duration curves of
pulse width and voltage 11 weeks following im-
plant again exhibited consistently lower chronic
values for the platinized electrode (Figure 4).
The small number of electrodes tested pre-
cisely at explant typically precluded any determi-
nation of significance between voltage and pulse
width thresholds for the platinized compared to
the polished platinum electrode versions. How-
ever, in comparison of all postimplant data ob-
tained from each electrode version for the dura-
tion of the study, the platinized electrode exhib-
ited a significant (P < .01) improvement in
threshold. Lead impedances and sensed myocar-
dial R waves remained comparable (Table I). His-
tologic evaluation demonstrated less reactive fi-
brotic infiltration associated with the platinized
(Figure 5) compared to the standard electrode site
(Figure 6).
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Figure 3. Serial ventricular thresholds at 0.5 milliseconds correlated over time illustrating
comparative effect of platinization over conventional polished electrode surface. N = 3 each lead.
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Figure 4. Mean strength-duration curves 11 weeks following implant.
Discussion
Although transvenous pacing systems are
now applicable to some pediatric patients, the
need for efficient epicardial pacing persists. This
need is most apparent in the very young, in chil-
dren with cardiac and vascular anomalies, which
preclude a transvenous lead approach, and those
who sustain conduction system damage during
cardiac surgery. Unfortunately, the increased
propensity for some children to develop electrode
site fibrosis and exit block has limited effective
chronic epicardial pacing by the requirement of
higher voltage output and diminished pulse gen-
erator longevity.P:" Although recent improve-
ments in implant technique have helped to allevi-
ate this problem, epicardial pacing in the imma-
ture myocardium remains less efficient than
comparable transvenous, endocardial pacing sys-
tems.
The recent advances seen with transvenous
electrodes have been lacking for comparable epi-
cardial systems. These include steroid-eluting
electrode which permits chronic voltage thresh-
olds approximately one-third of polished elec-
trodes and one-half of similar porous electrodes
without steroid.P" Another recent advance in
transvenous lead technology involves the appli-
cation of platinum black particles to the electrode
surface.I" This latter advancement has also dem-
onstrated efficient minimization of polarization
losses.to In experimental animal studies, chronic
thresholds at 0.5 ms were approximately one-
third of those of comparable polished platinum
ring tip electrodes.' Similar findings for pulse
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Figure 5. Histologic appearance of conventional smooth platinum-iridium electrode-epimyo-
cardial tissue interface. Arrows outline extension of fibrotic infiltration which appears as darker
stained material. Magnification 5X.
width threshold at 5.4 v have been reported for
human clinical studies."
This latter electrode technology has now
been extended to epicardial pacing systems with
comparable results. The ultra-fine surface texture
of the platinized electrode appears to be benefi-
cial for tissue acceptance of the foreign material.
This concept is especially applicable to the epi-
cardial implant surface where cellular reactivity
can be extensive. Macrophage activation in re-
sponse to the electrode and differentiation to mul-
tinucleated giant cells with release of lysosomal
enzymes and oxidants results in cytotoxic cell
damage , necrosis, and fibroblast proliferation.
Collagen eventually encapsulates the electrode
and replaces damaged myocardial tissue. If the
electrode .surface is modified to an ultra-small
particulate surface, then the inflammatory re -
sponse may be minimized. Macrophage prolifera-
tion and differentiation with ultimate collagen
accumulation may be limited.This would result in
a thinner fibrotic capsule and lower chronic
thresholds. Studies are now underway to eluci-
date this hypothesis." In addition, the highly ef-
fective surface area minimizes polarization losses,
permitting substantially more efficient transfer
from electronic (in metal) to ionic (in tissue) con-
duction.v"
These assumptions were supported in part
during the histologic evaluation. The platinized
1146 August 1988 PACE, Vol. 11
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Figure 6. Comparative histologic appearance ofnew "platinized" electrode-epimyocardial tis-
sue interface in small animal at comparable electrode postion in Figure 5. Arrows outline lim ited
extent offibrotic infiltration. Magnification 5X.
electrode sites exhibited consistently less fibrotic
infiltration than the smooth platinium-iridium
sites.
Although this initial study was conducted on
a small number of animals, these preliminary
findings of improved pacing and sensing capabili-
ties of piatinized epicardial electrodes would indi-
cate that epicardial pacing systems can be as effi-
cient as current endocardial leads with wide ap-
plication to the immature myocardium. The
study was continued for 16 weeks after implant to
assure chronic electrode stabilization. Due to this
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